| Dr Jason Shattuck, MD | |
|
707 N Emerson Ave, Wenatchee, WA 98801-2032 | |
| (509) 663-8711 | |
| Not Available |
| Full Name | Dr Jason Shattuck |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 20 Years |
| Location | 707 N Emerson Ave, Wenatchee, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255541371 | NPI | - | NPPES |
| 1255541371 | Medicaid | WA | |
| P01256392 | Other | WA | RR MEDICARE |
| 0251500 | Other | WA | L&I |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD60079338 (Washington) | Secondary |
| 208000000X | Pediatrics | MD60079338 (Washington) | Secondary |
| 208M00000X | Hospitalist | MD60079338 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Central Washington Hospital | Wenatchee, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Washington Health Services Association | 4880504596 | 645 |
News Archive
Over the years, COST Actions have become one the main instrument for research collaboration in Europe.
Many Americans do not have access to a "medical home"-a physician practice that is able to manage ongoing care for patients and coordinate care among specialists and other health care facilities, according to a University of Michigan Health System-led study.
Onyx Pharmaceuticals, Inc. today announced results from a Bayer HealthCare Pharmaceuticals Phase 3 trial evaluating the investigational compound regorafenib (BAY 73-4506) for the treatment of patients with metastatic colorectal cancer (mCRC) whose disease has progressed after approved standard therapies.
Prince Charles has entered the obesity debate and has cautioned the British public against becoming like the 'super size' Americans.
› Verified 3 days ago
| Entity Name | Central Washington Health Services Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801937453 PECOS PAC ID: 4880504596 Enrollment ID: O20031106000287 |
News Archive
Over the years, COST Actions have become one the main instrument for research collaboration in Europe.
Many Americans do not have access to a "medical home"-a physician practice that is able to manage ongoing care for patients and coordinate care among specialists and other health care facilities, according to a University of Michigan Health System-led study.
Onyx Pharmaceuticals, Inc. today announced results from a Bayer HealthCare Pharmaceuticals Phase 3 trial evaluating the investigational compound regorafenib (BAY 73-4506) for the treatment of patients with metastatic colorectal cancer (mCRC) whose disease has progressed after approved standard therapies.
Prince Charles has entered the obesity debate and has cautioned the British public against becoming like the 'super size' Americans.
› Verified 3 days ago
| Entity Name | Chelan County Public Hospital District No 2 |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578568853 PECOS PAC ID: 9133027360 Enrollment ID: O20031226000201 |
News Archive
Over the years, COST Actions have become one the main instrument for research collaboration in Europe.
Many Americans do not have access to a "medical home"-a physician practice that is able to manage ongoing care for patients and coordinate care among specialists and other health care facilities, according to a University of Michigan Health System-led study.
Onyx Pharmaceuticals, Inc. today announced results from a Bayer HealthCare Pharmaceuticals Phase 3 trial evaluating the investigational compound regorafenib (BAY 73-4506) for the treatment of patients with metastatic colorectal cancer (mCRC) whose disease has progressed after approved standard therapies.
Prince Charles has entered the obesity debate and has cautioned the British public against becoming like the 'super size' Americans.
› Verified 3 days ago
| Entity Name | Chelan County Public Hospital District No 2 |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1578568853 PECOS PAC ID: 9133027360 Enrollment ID: O20061104000289 |
News Archive
Over the years, COST Actions have become one the main instrument for research collaboration in Europe.
Many Americans do not have access to a "medical home"-a physician practice that is able to manage ongoing care for patients and coordinate care among specialists and other health care facilities, according to a University of Michigan Health System-led study.
Onyx Pharmaceuticals, Inc. today announced results from a Bayer HealthCare Pharmaceuticals Phase 3 trial evaluating the investigational compound regorafenib (BAY 73-4506) for the treatment of patients with metastatic colorectal cancer (mCRC) whose disease has progressed after approved standard therapies.
Prince Charles has entered the obesity debate and has cautioned the British public against becoming like the 'super size' Americans.
› Verified 3 days ago
| Entity Name | Wenatchee Valley Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669719688 PECOS PAC ID: 9537309869 Enrollment ID: O20130716000034 |
News Archive
Over the years, COST Actions have become one the main instrument for research collaboration in Europe.
Many Americans do not have access to a "medical home"-a physician practice that is able to manage ongoing care for patients and coordinate care among specialists and other health care facilities, according to a University of Michigan Health System-led study.
Onyx Pharmaceuticals, Inc. today announced results from a Bayer HealthCare Pharmaceuticals Phase 3 trial evaluating the investigational compound regorafenib (BAY 73-4506) for the treatment of patients with metastatic colorectal cancer (mCRC) whose disease has progressed after approved standard therapies.
Prince Charles has entered the obesity debate and has cautioned the British public against becoming like the 'super size' Americans.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jason Shattuck, MD 820 N Chelan Ave, Wenatchee, WA 98801-2028 Ph: () - | Dr Jason Shattuck, MD 707 N Emerson Ave, Wenatchee, WA 98801-2032 Ph: (509) 663-8711 |
News Archive
Over the years, COST Actions have become one the main instrument for research collaboration in Europe.
Many Americans do not have access to a "medical home"-a physician practice that is able to manage ongoing care for patients and coordinate care among specialists and other health care facilities, according to a University of Michigan Health System-led study.
Onyx Pharmaceuticals, Inc. today announced results from a Bayer HealthCare Pharmaceuticals Phase 3 trial evaluating the investigational compound regorafenib (BAY 73-4506) for the treatment of patients with metastatic colorectal cancer (mCRC) whose disease has progressed after approved standard therapies.
Prince Charles has entered the obesity debate and has cautioned the British public against becoming like the 'super size' Americans.
› Verified 3 days ago
Michelle N Straus, MD Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 Fax: 509-665-6065 | |
Ellen Mccleery, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 1201 S Miller St, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Stephen F Lewis, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Katherine M Arkwright, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1201 S Miller St, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Dr. Rocky Singh Behniwal, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1201 S Miller St, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Jeffery Armaly, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1201 S Miller St, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Dr. Mihret M Asressahegn, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 |